Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 3

Get the latest international news and world events from around the world.

Log in for authorized contributors

Are We Living Inside a Hologram? | Jim Al-Khalili’s Guide To Life

Jim Al-Khalili explores the revolutionary discoveries that transformed modern physics. From Einstein’s General Theory of Relativity and the expanding universe to the bizarre world of quantum mechanics, black holes, entanglement, and the search for a Theory of Everything, this episode examines the ideas that continue to redefine our understanding of space, time, and reality itself. It concludes with one of the boldest concepts in theoretical physics—that the universe may actually be a giant hologram.

Now available on SPOTIFY! ► https://tinyurl.com/2kr4kb2d.

►Subscribe – http://goo.gl/wpc2Q1

International Group of Researchers Says We’re Thinking About Longevity at The Wrong Stage of Life

The science of longevity is an important topic for many researchers: how we might add years to our lifespans, and avoid disease and age-related decline at the same time.

There are a multitude of angles to approach the topic from too, whether it’s the genetics we’re born with or the food we eat along life’s journey.

Now, an international team of researchers is proposing that longevity interventions and research should start at the earliest ages possible – even before birth.

Pentagon disburses Havana Syndrome compensation, rebrands team focused on ‘Directed Energy BioEffects’

The Defense Department has paid out millions of dollars to personnel affected by so-called Havana Syndrome and renamed a key cross-functional team as the Directed Energy Bio-Effects CFT to investigate associated issues, the Pentagon announced Friday.

According to a press release, the disbursements were the first payments associated with the 2021 HAVANA Act made under any presidential administration. The release did not say how many individuals have received compensation thus far.

The term ‘Havana Syndrome’ emerged after U.S. government personnel and their family members began reporting mysterious, often debilitating symptoms including intense ear pain, vertigo, headaches, dizziness, hearing and memory loss, visual disturbances and more in 2016. The first incidents were reported by officials who were stationed at the U.S. Embassy in Havana, Cuba, hence the origin of the name.

Some experts and lawmakers have suggested that these health problems resulted from secretive attacks by a foreign power that used directed energy systems, also known as ‘non-kinetic’ capabilities, targeted at American officials overseas.

The Pentagon has paid out millions of dollars to personnel affected by so-called Havana Syndrome and renamed a related cross-functional team.

Immune therapy for Alzheimer’s takes a step forward: Phase I trial reports positive results

Dozens of research teams around the world are working to halt, treat and even prevent Alzheimer’s disease, which silently develops in the brain for more than a decade before symptoms appear. Although recent years have brought important advances, researchers continue to search for therapies that can more effectively alter the course of Alzheimer’s and other forms of dementia.

Professor Michal Schwartz of the Weizmann Institute of Science’s Brain Sciences Department has developed an innovative strategy for treating Alzheimer’s disease. A recipient of the Israel Prize in Life Sciences, Schwartz pioneered research showing that the body’s most protected organ—the brain—is tightly dependent on the immune system for its lifelong functioning, maintenance and repair.

These findings overturned the long-held dogma that the brain was entirely isolated from immune activity and that any immune activity within the brain was inherently detrimental and should therefore be suppressed.

Natural killer cells swarm and crossrecruit cytotoxic T cells via CCR5

Cremasco et al. demonstrate that NK cells engaging solid tumor targets can swarm via CCR5 and directly cross-recruit cytotoxic T cells through the same receptor. Using multi-step adoptive transfer protocols in vivo, a primary NK cell infusion enhances subsequent T cell tumor infiltration and improves tumor rejection.

Prognostic Value of Blood-Based P-Tau217 Levels for Progression to Cognitive Impairment

This cohort study examines the absolute risk of progression to cognitive impairment and rates of cognitive decline per the blood-based biomarker plasma phosphorylated tau 217 (p-tau217) among cognitively unimpaired older adults.

‘RNA can do things which we have never seen before’: New study challenges assumptions about what RNA was up to at the dawn of life

RNA can fold into more complex configurations than scientists thought, raising questions about how important these 3D structures were when life on Earth began.

/* */